Miocardiopatía hipertrófica

Maron, 2002, Hypertrophic cardiomyopathy: a systematic review, JAMA, 287, 1308, 10.1001/jama.287.10.1308 Maron, 2003, J Am Coll Cardiol, 42, 1687, 10.1016/S0735-1097(03)00941-0 Nagueh, 2006, Non-invasive cardiac imaging in patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, 48, 2410, 10.1016/j.jacc.2006.07.065 Haah, 2008, Prevalence of exercise-induced left ventricular outflow tract obstruction in symptomatic patients with non-obstructive hypertrophic cardiomyopathy, Heart, 94, 1288 Maron, 2006, Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction, Circulation, 114, 2232, 10.1161/CIRCULATIONAHA.106.644682 Maron, 2009, Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance, J Am Coll Cardiol, 54, 220, 10.1016/j.jacc.2009.05.006 Nazarian, 2008, Cardiovascular magnetic resonance for risk stratification of arrhythmia in hypertrophic cardiomyopathy, J Am Coll Cardiol, 51, 1375, 10.1016/j.jacc.2008.01.010 Wang, 2010, Narrative review: harnessing molecular genetics for the diagnosis and management of hypertrophic cardiomyopathy, Ann Intern Med, 152, 513, 10.7326/0003-4819-152-8-201004200-00008 Olivotto, 2001, Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy, Circulation, 104, 2517, 10.1161/hc4601.097997 Seggewiss, 2000, Percutaneous transluminal septal myocardial ablation: a new treatment for hypertrophic obstructive cardiomyopathy, Eur Heart J, 21, 704, 10.1053/euhj.1999.2019 Maron, 2000, Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population, Circulation, 102, 858, 10.1161/01.CIR.102.8.858 Sherrid, 2005, Multicenter study of the efficacy and safety of disopyramide in obstructive hypertrophic cardiomyopathy, J Am Coll Cardiol, 45, 1251, 10.1016/j.jacc.2005.01.012 Elliott, 2000, Sudden death in hypertrophic cardiomyopathy: identification of high risk patients, J Am Coll Cardiol, 36, 2212, 10.1016/S0735-1097(00)01003-2 Maron, 2010, Contemporary insights and strategies for risk stratification and prevention of sudden death in hypertrophic cardiomyopathy, Circulation, 121, 445, 10.1161/CIRCULATIONAHA.109.878579 Maron, 2000, Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy, N Engl J Med, 342, 365, 10.1056/NEJM200002103420601 Maron, 2002, Clinical profile of stroke in 900 patients with hypertrophic cardiomyopathy, J Am Coll Cardiol, 39, 301, 10.1016/S0735-1097(01)01727-2